Global Vaccine (Include COVID-19) Market Growth (Status and Outlook) 2025-2031
Description
The global Vaccine (Include COVID-19) market size is predicted to grow from US$ 60590 million in 2025 to US$ 75720 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Vaccine (Include COVID-19) Industry Forecast” looks at past sales and reviews total world Vaccine (Include COVID-19) sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccine (Include COVID-19) sales for 2025 through 2031. With Vaccine (Include COVID-19) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine (Include COVID-19) industry.
This Insight Report provides a comprehensive analysis of the global Vaccine (Include COVID-19) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vaccine (Include COVID-19) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine (Include COVID-19) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine (Include COVID-19) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine (Include COVID-19).
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine (Include COVID-19) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Inactivated Vaccine
Attenuated Vaccine
mRNA
Other
Segmentation by Application:
Public
Private
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
KM Biologics
Pfizer
Merck
Sinovac
Zhejiang Pukang
Walvax Biotechnology
Bharat Biotech
Serum Institute
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
LG Life Sciences
Please note: The report will take approximately 2 business days to prepare and deliver.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Vaccine (Include COVID-19) Industry Forecast” looks at past sales and reviews total world Vaccine (Include COVID-19) sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccine (Include COVID-19) sales for 2025 through 2031. With Vaccine (Include COVID-19) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine (Include COVID-19) industry.
This Insight Report provides a comprehensive analysis of the global Vaccine (Include COVID-19) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vaccine (Include COVID-19) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine (Include COVID-19) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine (Include COVID-19) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine (Include COVID-19).
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine (Include COVID-19) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Inactivated Vaccine
Attenuated Vaccine
mRNA
Other
Segmentation by Application:
Public
Private
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
KM Biologics
Pfizer
Merck
Sinovac
Zhejiang Pukang
Walvax Biotechnology
Bharat Biotech
Serum Institute
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
LG Life Sciences
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
126 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Vaccine (Include COVID-19) Market Size by Player
- 4 Vaccine (Include COVID-19) by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Vaccine (Include COVID-19) Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
